UMB Bank N.A.

Location

Missouri

Founded

1913-08-23

Risk Signals

160 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., National Commercial Banks), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about UMB Bank N.A.

Live alerts from global media, monitored by Business Radar

Kansas City bank triumphs in five-year legal battle over Thomas Hart Benton’s artworks

2024-12-17 (kansascity.com)

Kansas City bank triumphs in five-year legal battle over Thomas Hart Benton’s artworks

The long-running legal battle pitted a Kansas City bank against famous artist’s heirs. A judge ruled that UMB Bank managed estate fairly.

Read more
Auditor warns Central Falls detention center to improve finances amid debt settlement talks - Providence Business First

2024-12-09 (bizjournals.com)

Auditor warns Central Falls detention center to improve finances amid debt settlement talks - Providence Business First

Auditor warns Wyatt Detention Facility to improve finances amid talks with its bond trustee.

Read more
Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue - Bristol-Myers Squibb (NYSE:BMY)

2024-11-17 (benzinga.com)

Bristol-Myers Faces Renewed $6.7 Billion Lawsuit Over Drug Approval Delays Amid Resolved Trustee Issue - Bristol-Myers Squibb (NYSE:BMY)

Bristol-Myers faces a renewed $6.7 billion lawsuit, alleging delayed approval for drugs like Breyanzi, affecting contingent value rights holders' payments.

Read more
Map shows Shaya Prager’s property deals collapsing across US

2024-11-04 (therealdeal.com)

Map shows Shaya Prager’s property deals collapsing across US

Opal Holdings investor's holdings now face intersecting lawsuits and loan defaults as unusual ownership structure comes to light.

Read more
Bristol-Myers Win Offers Lessons For Debt Security Holders

2024-10-22 (law360.com)

Bristol-Myers Win Offers Lessons For Debt Security Holders

A New York federal judge's recent dismissal of a $6.4 billion lawsuit against Bristol-Myers Squibb, due to plaintiff UMB Bank's lack of standing, serves as an important reminder to debt security holders to obtain depositary proxies before pursuing litigation, say attorneys at Milbank.

Read more
Judge dismisses $6.4 billion lawsuit against Bristol Myers Squibb

2024-10-02 (thepharmaletter.com)

Judge dismisses $6.4 billion lawsuit against Bristol Myers Squibb

Bristol Myers Squibb won a legal victory as a New York judge dismissed a $6.4 billion lawsuit filed by UMB Bank on behalf of Celgene shareholders. The lawsuit alleged that Bristol Myers delayed drug approvals to avoid contingent value right (CVR) payments from its 2019 Celgene acquisition.

Read more
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug

2024-10-01 (pm360online.com)

Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug

(Reuters) - Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene.

Read more
Federal Judge Dismisses $6.4B Lawsuit Against BMS Over Celgene Acquisition

2024-10-01 (biospace.com)

Federal Judge Dismisses $6.4B Lawsuit Against BMS Over Celgene Acquisition

District Judge Jesse Furman ruled that the plaintiff, UMB Bank, does not have standing to bring the case against Bristol Myers Squibb because it is not a properly appointed trustee for shareholders’ contingent value rights.

Read more
Bristol Myers wins $6.4 billion lawsuit By Investing.com

2024-10-01 (investing.com)

Bristol Myers wins $6.4 billion lawsuit By Investing.com

Bristol Myers wins $6.4 billion lawsuit

Read more
Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug

2024-09-30 (reuters.com)

Bristol Myers beats $6.4 billion lawsuit over delayed cancer drug

Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene.

Read more
Ibrahim Mahama’s Lawyers demand Retraction and Apology from Manasseh over Alleged False Claims in New Book

2024-08-23 (ghananewsonline.com.gh)

Ibrahim Mahama’s Lawyers demand Retraction and Apology from Manasseh over Alleged False Claims in New Book

Lawyers representing Mr. Ibrahim Mahama, a prominent Ghanaian businessman and brother of former President John Dramani Mahama, have issued a stern demand for a retraction and apology from investigative journalist Manasseh Azure Awuni. The request fol

Read more
Bank claims New Jersey investor lied to score loan at Fort Worth’s tallest tower

2024-05-24 (therealdeal.com)

Bank claims New Jersey investor lied to score loan at Fort Worth’s tallest tower

Fort Worth’s tallest building ended up at a foreclosure auction earlier this month, but before the sale, former owner Shaya Prager was accused of lying to get an $83 million loan.

Read more

Never miss a headline about UMB Bank N.A.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages